Pentoxifylline: Clinical Trials

16 trials of Pentoxifylline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 unknown, 2 terminated, 1 not yet recruiting. 16 Phase 1, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 116Completed 9, Unknown 3, Terminated 2, Not yet recruiting 1, Withdrawn 1
Phase 210Completed 6, Unknown 2, Not yet recruiting 1, Withdrawn 1

Follow Pentoxifylline: new trials by email Literature Review of Pentoxifylline trials Research Report on Pentoxifylline

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pentoxifylline for Vascular Calcification in Kidney Disease
Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification
Phase 1 / Phase 2Not yet recruitingMansoura University802025-04-152025-04-01
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis
Phase 1 / Phase 2CompletedZiauddin University302024-08-122025-05-02
Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke
Pentoxifylline - Cognitive Impairment
Phase 1 / Phase 2UnknownThe First Hospital of Hebei Medical University2002024-04-102024-04-03
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin - Alopecia Areata
Phase 1UnknownAssiut University602023-10-012023-10-18
Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients
Pentoxifylline, Placebo - COVID
Phase 1 / Phase 2WithdrawnSadat City University2022-11-132023-01-18
Pentoxifylline for Treatment of Resistant Major Depression
Pentoxifylline, Placebo - Resistant Major Depression
Phase 1 / Phase 2CompletedHawler Medical University602021-12-152022-09-07
Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet) - Major Depressive Disorder
Phase 1 / Phase 2CompletedHawler Medical University1002021-11-102022-09-07
Pentoxifylline Add-on Therapy for Schizophrenia
Oxopurin - Schizophrenia
Phase 1 / Phase 2UnknownMazra Mental Health Center902019-04-202021-10-11
Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia
Placebo oral tablet, Pentoxifylline - Schizophrenia
Phase 1 / Phase 2CompletedSadat City University802019-01-012022-10-25
Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to TrentalĀ® Administered to Healthy Subjects
PCS499, Trental - Healthy
Phase 1CompletedProcessa Pharmaceuticals182018-02-262019-02-12
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy
Pentoxifylline - Muscular Dystrophy, Duchenne
Phase 1 / Phase 2CompletedCooperative International Neuromuscular Research Group642005-09-012011-10-27
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
pentoxifylline - Hepatitis, Alcoholic
Phase 1TerminatedUniversity of Wisconsin, Madison42005-03-012014-05-13
Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
pentoxifylline - Hepatopulmonary Syndrome
Phase 1TerminatedUniversity of Alabama at Birmingham92004-06-012015-03-09
Pentoxifylline in Duchenne Muscular Dystrophy
Pentoxifylline - Muscular Dystrophy, Duchenne
Phase 1 / Phase 2CompletedCooperative International Neuromuscular Research Group172002-03-012011-10-27
Radiation Therapy in Treating Patients With Glioblastoma
chemotherapy, hydroxyurea, pentoxifylline - Brain and Central Nervous System Tumors
Phase 1CompletedNational Cancer Institute (NCI)341995-04-012015-04-29
Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
Pentoxifylline - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)542021-11-02

Conditions studied

Muscular Dystrophy, Duchenne (2)  ·  Schizophrenia (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alopecia Areata (1)  ·  Bipolar Disorder (1)  ·  Cachexia (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Central Nervous System Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Depressive Disorder, Major (1)  ·  Fibrosis (1)  ·  Glioblastoma (1)  ·  Gliosarcoma (1)  ·  HIV Infections (1)  ·  Hepatitis, Alcoholic (1)

Sponsors

Cooperative International Neuromuscular Research Group (2)  ·  Hawler Medical University (2)  ·  Sadat City University (2)  ·  Assiut University (1)  ·  Mansoura University (1)  ·  Mazra Mental Health Center (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Processa Pharmaceuticals (1)  ·  The First Hospital of Hebei Medical University (1)  ·  University of Alabama at Birmingham (1)  ·  University of Wisconsin, Madison (1)  ·  Ziauddin University (1)

Countries

United States (5)  ·  Egypt (3)  ·  Iraq (2)  ·  Israel (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Italy (1)  ·  Pakistan (1)  ·  United Kingdom (1)

Top investigators

Diana Escolar, MD (2)  ·  Talar A Merzamohammad, Pharm. D (2)  ·  Brian G. Fuller, MD (1)  ·  Crumpacker C (1)  ·  Dezube B (1)  ·  Jiaying Rong, master (1)  ·  Michael B Fallon, MD (1)  ·  Michael R Lucey, MD (1)  ·  Nada K. Mostafa, bachelor (1)  ·  Sharan Sidhu, MBChB (1)

Results publications

PMID 18668653, PMID 28390753, PMID 30302901, PMID 31472446, PMID 33008091, PMID 34007848, PMID 35410255, PMID 36341700, PMID 36552855

NIH funding

R03DK065958 (1)